The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
University Hospital Southampton is implementing Aiforia’s PD-L1 lung cancer AI solution to assess PD-L1 staining in lung cancer specimens. Dr Vipul Foria and Dr Victoria Elliot describe their journey so far.
Researchers have developed a lung cancer treatment that delivers healthy mitochondria to tumours, boosting T cell activity and improving the effectiveness of cisplatin chemotherapy with reduced toxicity.
The Lancet Commission finds that over three in five liver cancer cases are due to modifiable risks like hepatitis, alcohol, and obesity, highlighting urgent prevention needs.
UCL and UCLH launch the Win‑Glio trial led by Dr Paul Mulholland, offering ipilimumab immunotherapy to newly diagnosed glioblastoma patients ahead of standard treatment.
The NHS Cancer Programme has awarded £14.4 million through SBRI Healthcare to support 16 pioneering projects aimed at improving early cancer detection and diagnosis across the UK.
New results from a clinical trial reveal that a single dose of psilocybin can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder.
A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161.
A new visualisation tool is shedding light on breast cancer spread. This innovative fluorescent probe, called Illusia, allows researchers to observe dynamic signalling within moving cancer cells, potentially opening new avenues for treatment and preventing metastatic spread.
The National Institute for Health and Care Research Great Ormond Street Hospital Biomedical Research Centre is developing a new virtual reality (VR) game to help children rehabilitate after brain tumour treatment.
World Cancer Research Fund International (WCRFI) is a not-for-profit organisation that leads a network of cancer prevention charities, including the American Institute for Cancer Research, World Cancer Research Fund in the UK, Wereld Kanker Onderzoek Fonds in the Netherlands and World Cancer Research Fund Hong Kong. They are dedicated to funding research on cancer, specifically how diet, weight, and physical activity affect cancer risk and survival.
The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis, as the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to its new artificial intelligence-powered companion diagnostic device, the VENTANA® TROP2 (EPR20043) RxDx.
